C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 333/38 (2006.01) A61K 31/381 (2006.01) A61P 25/28 (2006.01) A61P 37/00 (2006.01)
Patent
CA 2722255
Cyclopentyl (2S,4E)-2-amino-5-{3-[4-carbamoyl-5 (carbamoylamino)-2- thienyl]phenyl}pent-4-enoate; Cy-clopentyl 5-{3-[4-carbamoyl-5-(carbamoylamino)-2-thienyl]phenyl}-L- norvalinate; Cyclopentyl (2S,4E)-2-amino-5-{3-[4-car-bamoyl-5-(carbamoylamino)-2-thienyl]-5- methylphenyl}pent-4-enoate; Cyclopentyl (2S,4E)-2-amino-5-{5-[4-carbamoyl-5-(car-bamoylamino)-2-thienyl]-2- methylphenyl}pent-4-enoate; Cyclopentyl O-{3-[4-carbamoyl-5-(carbamoylamino)-2--thienyl]phenyl}-L-homoserinate; Cyclopentyl O-{3-[4-carbamoyl-5-(carbamoylamino)-2-thienyl]phenyl}-L- homoserinate; Cy-clopentyl N-{3-[4-carbamoyl-5-(carbamoylamino)-2-thienyl]benzyl}-L- alaninate; and tert-Butyl N-{3-[4-carbamoyl-5-(carbamoy-lamino)-2-thienyl]benzyl}-L-alaninate are hydrolysed to the corresponding carboxylic acids by intracellular carboxylesterases, and are useful for the inhibition of IKK.beta. activity.
Le (2S,4E)-2-amino-5-{3-[4-carbamoyl-5(carbamoylamino)-2-thiényl]phényl}pent-4-énoate de cyclopentyle ; le 5-{3-[4-carbamoyl-5-(carbamoylamino)-2-thiényl]phényl}-L-norvalinate de cyclopentyle ; le (2S,4E)-2-amino-5-{3-[4-carbamoyl-5-(carbamoylamino)-2-thiényl]-5-méthylphényl}pent-4-énoate de cyclopentyle ; le (2S,4E)-2-amino-5-{5-[4-carbamoyl-5-(carbamoylamino)-2-thiényl]-2-méthylphényl}pent-4-énoate de cyclopentyle ; le O-{3-[4-carbamoyl-5-(carbamoylamino)-2-thiényl]phényl}-L-homosérinate de cyclopentyle ; le O-{3-[4-carbamoyl-5-(carbamoylamino)-2-thiénylphényl}-L-homosérinate de cyclopentyle ; le N-{3-[4-carbamoyl-5-(carbamoylamino)-2-thiényl]benzyl}-L-alaninate de cyclopentyle ; et le N-{3-[4-carbamoyl-5-(carbamoylamino)-2-thiényl]benzyl}-L-alaninate de tert-butyle sont hydrolysés en les acides carboxyliques correspondants par des carboxylestérases intracellulaires et sont utiles pour l'inhibition de l'activité d'IKK-ß.
Charles Moffat David Festus
Christopher Hirst Simon
Gareth Williams Jonathon
Hugh Charlton Michael
John Davies Stephen
Chroma Therapeutics Ltd.
Gowling Lafleur Henderson Llp
LandOfFree
Inhibitors of ikk-.beta. serine-threonine protein kinase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of ikk-.beta. serine-threonine protein kinase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of ikk-.beta. serine-threonine protein kinase will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1782240